Review Series


                                                   

                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                            
                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                        
                                                    
                                                        
                                                                                                                                                                                                                                                                                                

June 2024: Immunotherapy for childhood malignancies

December 2023: Peripheral T-Cell Lymphomas

February 2023: Acute Myeloid Leukemia

December 2022: Measurable Residual Disease

June 2022: Treatment of thrombocytopenias

January 2022: Indolent lymphomas